Marshall Wace
NXTM

Marshall Wace’s NxStage Medical Inc. NXTM Stock Holding History

Marshall Wace’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,393,302
Closed -$39.9M – 2254
2018
Q4 		$39.9M Buy
1,393,302
+244,760
+21% +$6.95M 0.41% 45
2018
Q3 		$32M Buy
1,148,542
+274,664
+31% +$7.72M 0.27% 96
2018
Q2 		$24.4M Sell
873,878
-141,097
-14% -$3.78M 0.36% 80
2018
Q1 		$25.2M Buy
1,014,975
+739,786
+269% +$18M 1.05% 22
2017
Q4 		$6.67M Buy
275,189
+209,249
+317% +$5.51M 0.28% 79
2017
Q3 		$1.85M Buy
+65,940
New +$1.76M 0.09% 167
2017
Q1 		– Sell
-228,002
Closed -$5.98M – 911
2016
Q4 		$5.98M Buy
+228,002
New +$5.64M 0.04% 428
2016
Q3 		– Sell
-205,492
Closed -$4.46M – 1232
2016
Q2 		$4.46M Buy
205,492
+166,406
+426% +$2.97M 0.04% 413
2016
Q1 		$586K Buy
+39,086
New +$655K 0.01% 823

Other funds holding NXTM

TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Marshall Wace's NXTM Position: Q1 2019 in Review

Marshall Wace sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 1,393,302 shares — an estimated $39.9M sold.

Marshall Wace first reported a position in NXTM in Q1 2016 and held it in 9 quarters. The position peaked at $39.9M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Marshall Wace reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Marshall Wace sold 1,393,302 NxStage Medical Inc. shares in Q1 2019, an estimated $39.9M.
  • Marshall Wace first reported a position in NxStage Medical Inc. in Q1 2016 and held it in 9 quarters.
  • Marshall Wace's NxStage Medical Inc. position peaked at $39.9M in Q4 2018.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Marshall Wace's 13F filing for Q1 2019, filed 14 May 2019.